About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 20 record(s)
Req # A-2023-000008
The most recent draft copy of the State of Per and Polyfluoroalkyl Substances (PFAS) Report being prepared by Health Canada.Organization: Health Canada
September 2023
Req # A-2023-001
Copy of personal information related to an investigation.Organization: Office of the Public Sector Integrity Commissioner of Canada
July 2023
Req # A-2023-002
Copy of personal information related to an investigation.Organization: Office of the Public Sector Integrity Commissioner of Canada
July 2023
Req # A-2021-001603
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the cover letter from the drug sponsor.Organization: Health Canada
April 2022
Req # A-2021-001600
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the proposed Certified Product Information Document.Organization: Health Canada
February 2022
Req # A-2021-001601
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Batch Formula” (3.2.P.3.2).Organization: Health Canada
February 2022
Req # A-2021-001602
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Description of Manufacturing Process and Process Controls” (3.2.P.3.3).Organization: Health Canada
February 2022
Req # A-2021-001605
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the proposed Product Monograph.Organization: Health Canada
February 2022
Req # A 2019_0008
Records from the Canada Development Investment Corporation related to the Trans Mountain Pipeline and Pipeline Expansion projects. Specifically: A copy of the Credit Agreements(s) with Her Majesty in Right of Canada doing business as Export Development Canada on behalf of the Canada Account and the Trans Mountain Project Finance (TMP Finance). Include documentation related to the following facilities: Acquisition; Construction; NEB. Include an amortization schedule that demonstrate the planned repayment of interest and principal. Any currently available transaction records (dated January 2019 or later) reflecting draws against the credit lines for the three facilities. A copy of the Credit Agreement(s) between Trans Mountain Project Finance and Trans Mountain Corporation. Any agreements from funders other than the Canada Account/EDC that provide funds for the closing in May 2018. Include copies of any Credit or other agreements that detail terms and conditions, as well as related amortization schedules if applicable. Exclude: draft documents, duplicates, e-mails, media monitoring, French documents if they exist in an English format, portions of documents that have no relevancy to the subject of the request.Organization: Canada Development Investment Corporation
March 2021
Req # A 2019_0016
The Nov 2019 agenda that Stephen Swaffield received for the Nov 2019 meeting of the Board of Directors of Trans Mountain Corporation. Please include any attachments, appendices and minutes.Organization: Canada Development Investment Corporation
March 2021